CRISPR/Cas: A Successful Tool for Genome Editing in Animal Models

被引:8
|
作者
Ahmed, Bilal [1 ]
Arif, Mashaal [2 ]
Qadir, Muhammad Imran [2 ]
机构
[1] Nanjing Med Univ, Sch Pharm, Nanjing, Jiangsu, Peoples R China
[2] Bahauddin Zakariya Univ, Inst Mol Biol & Biotechnol, Multan, Pakistan
来源
关键词
zinc finger nuclease; homology-directed repair; guide RNA; GENE; CAS; MUTAGENESIS; DROSOPHILA; SEQUENCE; RNA;
D O I
10.1615/CritRevEukaryotGeneExpr.2020028791
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
CRISPR/Cas9 is an innovative molecular tool that is utilized in advanced biological applications. This review focuses on modifying the genomes of a wide range of animals by CRISPR/Cas9 for greater usability and higher efficiency, providing an overview of the function and mechanism of this system and the utilization of this system for medicinal research. The type II CRISPR-Cas system is found in the Enterobacteriaceae bacteria family, which uses this system as a defense against invading phages and plasmids. This system can be engineered to direct its action toward a targeted site for the modification of a specific genome.
引用
收藏
页码:239 / 243
页数:5
相关论文
共 50 条
  • [31] Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities
    Lohia, Aayushi
    Sahel, Deepak Kumar
    Salman, Mohd
    Singh, Vivek
    Mariappan, Indumathi
    Mittal, Anupama
    Chitkara, Deepak
    ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 17 (02) : 153 - 176
  • [32] Delivery strategies for CRISPR/Cas genome editing tool for retinal dystrophies: challenges and opportunities
    Aayushi Lohia
    Deepak Kumar Sahel
    Mohd Salman
    Vivek Singh
    Indumathi Mariappan
    Anupama Mittal
    Deepak Chitkara
    Asian Journal of Pharmaceutical Sciences, 2022, 17 (02) : 153 - 176
  • [33] CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
    Baghini, Sadegh Shojaei
    Gardanova, Zhanna R.
    Abadi, Saeme Azizi Hassan
    Zaman, Burhan Abdullah
    Ilhan, Ahmet
    Shomali, Navid
    Adili, Ali
    Moghaddar, Roozbeh
    Yaseri, Amirhossein Fakhre
    CELLULAR & MOLECULAR BIOLOGY LETTERS, 2022, 27 (01)
  • [34] CRISPR-Cas for Fungal Genome Editing: A New Tool for the Management of Plant Diseases
    Munoz, Isabel Vicente
    Sarrocco, Sabrina
    Malfatti, Luca
    Baroncelli, Riccardo
    Vannacci, Giovanni
    FRONTIERS IN PLANT SCIENCE, 2019, 10
  • [35] Mini CRISPR-Cas12f1: a new genome editing tool
    Awan, Muhammad Jawad Akbar
    Amin, Imran
    Mansoor, Shahid
    TRENDS IN PLANT SCIENCE, 2022, 27 (02) : 110 - 112
  • [36] CRISPR/Cas9 application in cancer therapy: a pioneering genome editing tool
    Sadegh Shojaei Baghini
    Zhanna R. Gardanova
    Saeme Azizi Hassan Abadi
    Burhan Abdullah Zaman
    Ahmet İlhan
    Navid Shomali
    Ali Adili
    Roozbeh Moghaddar
    Amirhossein Fakhre Yaseri
    Cellular & Molecular Biology Letters, 2022, 27
  • [37] Retron Library Recombineering: Next Powerful Tool for Genome Editing after CRISPR/Cas
    Kaur, Navdeep
    Pati, Pratap Kumar
    ACS SYNTHETIC BIOLOGY, 2024, 13 (04): : 1019 - 1025
  • [38] CRISPR-Cas Technology as a Revolutionary Genome Editing tool: Mechanisms and Biomedical Applications
    Ebrahimi, Sahar
    Khosravi, Mohammad Ali
    Raz, Abbasali
    Karimipoor, Morteza
    Parvizi, Parviz
    IRANIAN BIOMEDICAL JOURNAL, 2023, 27 (05) : 219 - 246
  • [39] CRISPR/Cas9: A revolutionary genome editing tool for human cancers treatment
    Akram, Fatima
    ul Haq, Ikram
    Sahreen, Sania
    Nasir, Narmeen
    Naseem, Waqas
    Imitaz, Memoona
    Aqeel, Amna
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2022, 21
  • [40] CRISPR/Cas9 Genome Editing Tool: A Promising Tool for Therapeutic Applications on Respiratory Diseases
    Shaikh, Sadiya Bi
    Bhandary, Yashodhar Prabhakar
    CURRENT GENE THERAPY, 2020, 20 (05) : 333 - 346